These results were confirmed in lung tumours and xenografts from mice bearing mutant EGFR-dependent lung adenocarcinomas, which also display increased concentrations of BIM after erlotinib treatment [27]. The gene discussed is EGFR; the disease is lung adenocarcinoma.